Benitec Biopharma Inc.BNTCNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
-164.22%
↓ 123% below average
Average (39q)
698.98%
Historical baseline
Range
High:42909.13%
Low:-10300.00%
CAGR
+2.1%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -164.22% |
| Q2 2025 | 362.26% |
| Q1 2025 | -30.86% |
| Q4 2024 | 10.99% |
| Q3 2024 | 0.00% |
| Q2 2024 | -1.11% |
| Q1 2024 | -8900.00% |
| Q4 2023 | -100.94% |
| Q3 2023 | 237.66% |
| Q2 2023 | -242.59% |
| Q1 2023 | 285.71% |
| Q4 2022 | 113.73% |
| Q3 2022 | -1033.33% |
| Q2 2022 | -118.75% |
| Q1 2022 | 92.00% |
| Q4 2021 | 124.51% |
| Q3 2021 | -10300.00% |
| Q2 2021 | 116.67% |
| Q1 2021 | -130.00% |
| Q4 2020 | 125.32% |
| Q3 2020 | 10.23% |
| Q2 2020 | -363.16% |
| Q1 2020 | -105.72% |
| Q4 2019 | 4642.86% |
| Q3 2019 | -98.86% |
| Q2 2019 | 15.66% |
| Q1 2019 | -90.23% |
| Q4 2018 | 1.74% |
| Q3 2018 | 42909.13% |
| Q2 2018 | 77.79% |
| Q1 2018 | -146.53% |
| Q4 2017 | 66.92% |
| Q3 2017 | 31.79% |
| Q2 2017 | 27.74% |
| Q1 2017 | 39.26% |
| Q4 2016 | -54.64% |
| Q3 2016 | 711.14% |
| Q2 2016 | -76.47% |
| Q1 2016 | -12.32% |
| Q4 2015 | -74.36% |